Search - tctmd.com

Displaying 221 - 240 of 265

Sort: Relevancy | Date

News Daily News

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

August 30, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

Presentation

Triple Antithrombotic Therapy Is the Independent Predictor of Major Bleeding Complications

Presenter: Y. Naruse

August 26, 2013

News Daily News

Los GPI son Superiores al Tratamientos de Rescate tras una Embolización Endovascular con Espirales contra Aneurismas Cerebrales

Caitlin E. Cox

May 03, 2013

News Daily News

GPIs Superior for Rescue Treatment after Endovascular Coiling for Cerebral Aneurysm

Caitlin E. Cox

May 03, 2013

News Daily News

ESC Offers Recommendations on Use of New Oral Anticoagulants

Yael L. Maxwell

May 03, 2013

News Daily News

Bivalirudin Bests Heparin for Lowering Bleeding Risk After CAS

L.A. McKeown

April 26, 2013

News Conference News ACC 2013

Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients

L.A. McKeown

March 09, 2013

News Conference News ACC 2013

Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients

Yael L. Maxwell

March 09, 2013

News Daily News

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

Caitlin E. Cox

March 09, 2013

News Daily News

Prasugrel Reloading Feasible After Clopidogrel Pretreatment in ACS Patients

Yael L. Maxwell

January 13, 2013

News Daily News

Genetic Alleles Affect Response to Prasugrel in ACS Patients

Jason Kahn

December 17, 2012

News Daily News

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

L.A. McKeown

November 28, 2012

News Conference News AHA 2012

No Mortality Benefit with Prolonged Dual Antiplatelet Therapy

November 05, 2012

News Daily News

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

October 12, 2012

News Daily News

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

September 27, 2012

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

L.A. McKeown

September 18, 2012

News Daily News

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

L.A. McKeown

August 20, 2012

News Daily News

Pantoprazole Not Necessarily a Safer PPI Choice for Patients on Dual Antiplatelet Therapy

L.A. McKeown

August 01, 2012

News Daily News

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Jason Kahn

July 17, 2012

Advertisement

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

Triple Antithrombotic Therapy Is the Independent Predictor of Major Bleeding Complications

Los GPI son Superiores al Tratamientos de Rescate tras una Embolización Endovascular con Espirales contra Aneurismas Cerebrales

GPIs Superior for Rescue Treatment after Endovascular Coiling for Cerebral Aneurysm

ESC Offers Recommendations on Use of New Oral Anticoagulants

Bivalirudin Bests Heparin for Lowering Bleeding Risk After CAS

Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients

Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

Prasugrel Reloading Feasible After Clopidogrel Pretreatment in ACS Patients

Genetic Alleles Affect Response to Prasugrel in ACS Patients

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

No Mortality Benefit with Prolonged Dual Antiplatelet Therapy

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

Pantoprazole Not Necessarily a Safer PPI Choice for Patients on Dual Antiplatelet Therapy

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content